Related Experiment Video
Updated: Jan 21, 2026
08:07
Author Spotlight: Advancing Labor Management Through Electromyometrial Imaging for Understanding Uterine Contractions
Published on: May 26, 2023
1.8K
Uterine Carcinosarcomas.
T L Sagebiel1, P R Bhosale1, M Patnana1
1The University of Texas MD Anderson Cancer Center, Diagnostic Radiology, T. Boone Pickens Academic Tower (FCT15.5023), Houston, TX.
Seminars in Ultrasound, CT, and MR
|August 4, 2019
Summary
Uterine carcinosarcoma (UCS) is a rare, aggressive endometrial cancer with both epithelial and sarcomatous parts. This review covers UCS epidemiology, pathology, imaging, and treatment options.
Area of Science:
- Gynecologic Oncology
- Pathology
- Radiology
Background:
- Uterine carcinosarcoma (UCS) is an uncommon and highly aggressive malignancy.
- It exhibits a biphasic histology, containing both epithelial and mesenchymal components.
Purpose of the Study:
- To provide a comprehensive overview of uterine carcinosarcoma.
- To discuss current understanding of its epidemiology, classification, staging, imaging features, prognosis, and therapeutic strategies.
Main Methods:
- Literature review of epidemiology, pathology, and imaging.
- Synthesis of information on current treatment modalities and prognostic factors.
Main Results:
- UCS presents unique diagnostic challenges due to its mixed histology.
- Imaging modalities reveal characteristic, though variable, findings.
- Prognosis remains poor, necessitating multimodal treatment approaches.
Conclusions:
- Accurate diagnosis and staging are crucial for effective management of UCS.
- Multidisciplinary care involving gynecologic oncologists, pathologists, and radiologists is essential.
- Further research into novel therapeutic strategies is warranted to improve patient outcomes.
